切换至 "中华医学电子期刊资源库"

中华实验和临床感染病杂志(电子版) ›› 2016, Vol. 10 ›› Issue (06) : 659 -662. doi: 10.3877/cma.j.issn.1674-1358.2016.06.003

综述

肠黏膜屏障功能障碍在重症急性胰腺炎中的研究进展
陈辉1, 兰涛1,()   
  1. 1. 061000 沧州市,南方医科大学附属沧州市人民医院肝胆胰外科
  • 收稿日期:2015-08-28 出版日期:2016-12-15
  • 通信作者: 兰涛
  • 基金资助:
    河北省卫生厅医学研究课题(No. 1120140016)

Progress of intestinal mucosal barrier dysfunction in severe acute pancreatitis

Hui Chen1, Tao Lan1,()   

  1. 1. Department of Hepatobiliary and Pancreatic Surgery, Cangzhou People’s Hospital, Southern Medical University, Cangzhou 061000, China
  • Received:2015-08-28 Published:2016-12-15
  • Corresponding author: Tao Lan
引用本文:

陈辉, 兰涛. 肠黏膜屏障功能障碍在重症急性胰腺炎中的研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2016, 10(06): 659-662.

Hui Chen, Tao Lan. Progress of intestinal mucosal barrier dysfunction in severe acute pancreatitis[J/OL]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Edition), 2016, 10(06): 659-662.

重症急性胰腺炎(SAP)病情险恶、并发症多,且病死率高。过去几十年来,SAP发病率显著增加,SAP可导致肠道黏膜屏障损伤,从而引起细菌或内毒素易位,继而出现胰腺组织继发感染,导致全身炎症反应综合征(SIRS)及多器官功能障碍综合征,进而影响SAP患者的预后。在SAP发病过程中肠黏膜屏障损伤具有重要作用。因此,对肠道黏膜屏障功能障碍在SAP发病机制研究中尤为重要。现将重症急性胰腺炎肠黏膜屏障功能障碍的研究进展进行综述。

Severe acute pancreatitis (SAP) is a severe disease, with many complications and high fatality rate. In the past few decades, the incidence rate of SAP increased significantly, which could damage the intestinal mucosa barrier, lead to bacterial and endotoxin translocation, pancreatic tissue infection, and then systemic inflammatory response syndrome (SIRS) and multiple organ dysfunction syndrome, eventually affects the prognosis of the patients. During SAP, intestinal mucosa barrier damage plays a key role. Therefore, the research of intestinal mucosal barrier dysfunction mechanism in SAP is important. The progress of intestinal mucosal barrier dysfunction in SAP were reviewed.

1
Werner J, Feuerbach S, Uhl W, et al. Management of acute pancreatitis: from surgery to interventional intensive care[J]. Gut,2005,54(3):426-436.
2
van Baal MC, van Santvoort HC, Bollen TL, et al. Systematic review of percutaneous catheter drainage as primary treatment for necrotizing pancreatitis[J]. Br J Surg,2011,98(1):18-27.
3
Zerem E, Imamović G, Sušić A, et al. Step-up approach to infected necrotising pancreatitis: a 20-year experience of percutaneous drainage in a single centre[J]. Dig Liver Dis,2011,43(6):478-483.
4
Rebours V. Acute pancreatitis: an overview of the management[J]. Rev Med Interne,2014,35(10):649-655.
5
曲鹏飞,苗彬,崔乃强. 重症急性胰腺炎感染与肠屏障学术进展[J]. 中国中西医结合外科杂志,2008,14(3):307-309.
6
Garside P, Millington O, Smith KM. The anatomy of mucosal immune responses[J]. Ann N Y Acad Sci,2004,1029(1):9-15.
7
Yang YJ, Gao NR. Influence of endogenous nitrogen monoxidum on permeability of intestinal mucosa of rats with acute necrotic pancreatitis[J]. World Chin J Digestol,2005,13(3):389-391.
8
张浩,崔乃强. 肠屏障与多器官功能障碍综合征[J]. 中国中西医结合外科杂志,2007,13(3):316-318.
9
Man AL, Gicheva N, Nicoletti C. The impact of ageing on the intestinal epithelial barrier and immune system[J]. Cell Immunol,2014,289(1-2):112-118.
10
Rahman SH, Ammori BJ, Holmfield J, et al. Intestinal hypoperfusion contributes to gut barrier failure in severe acute pancreatitis[J]. J Gastrointest Surg,2003,7(1):26-35.
11
Zhang JX, Qu JG, Cheng GZ, et al. Changes of intestinal blood flow and phospholipase A2, interleukin-1β in serum of rats with acute necrotic pancreatitis[J]. Basic Med Sci Clin,2003,23(5):556-558.
12
Shames BD, Barton HH, Reznikov LL, et al. Ischemia alone is sufficient to induce TNF-alpha mRNA and peptide in the myocardium[J]. Shock,2002,17(2):114-119.
13
Kianian M, Kelly ME, Zhou J, et al. Cannabinoid receptor 1 inhibition improves the intestinal microcirculation[J]. Clin Hemorheol Microcirc,2014,58(2):333-342.
14
Yang FR, Lin XZ. Study progress on intestinal ischemical reperfusion injury[J]. Chin J Integr Tradit Western Med,2002,8(4):319-321.
15
Qiu Y, Yu M, Yang Y, et al. Disturbance of intraepithelial lymphocytes in a murine model of acute intestinal ischemia/reperfusion[J]. J Mol Histol,2014,45(2):217-227.
16
Tian R, Tan JT, Wang RL, et al. The role of intestinal mucosa oxidative stress in gut barrier dysfunction of severe acute pancreatitis[J]. Eur Rev Med Pharmacol Sci,2013,17(3):349-355.
17
耿艳霞,黎介寿. 表皮生长因子对大鼠小肠缺血-再灌注损伤的保护作用[J]. 肠外与肠内营养杂志,2013,20(1):29-32.
18
Wang XP, Wang BX, Wu K, et al. Excessive cytokine expression mediated by NF-κB of intestinal mucosa and role of somatropin in acute necrotic pancreatitis[J]. Chin J Hepatobiliary Surg,2003,9(1):45-49.
19
Ji L, Yuan YZ, Xu JY. NF-κB and acute pancreatitis[J]. Forei Med Intern Med,2000,27(9):396-398.
20
Yin JB, Xiao JM, Wang YQ, et al. Acute pancreatitis and intestinal barrier injury, bacteria translocation and endotoxemia[J]. Chin J Coal Ind Med,2005,8(4):317-320.
21
Lu ZK,Ye JX, Chen WC. Vasoactive intestinal peptide promotes gut barrier function against severe acute pancreatitis[J]. Mol Biol Rep,2012,39(4):3557-3563.
22
Chen X, Zhao HX, Fu XS, et al. Glucagonlike peptide 2 protects intestinal barrier in severe acute pancreatitis through regulating intestinalepithelial cell proliferation and apoptosis[J]. Pancreas,2012,41(7):1080-1085.
23
Rao RK, Samak G2. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications[J]. Curr Nutr Food Sci,2013,9(2):99-107.
24
Han T, Li XL, Cai DL, et al. Effects of glutamine-supplemented enteral or parenteral nutrition on apoptosis of intestinal mucosal cells in rats with severe acute pancreatitis[J]. Eur Rev Med Pharmacol Sci,2013,17(11):1529-1535.
25
Grady EF, Yoshimi SK, Maa J, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice[J]. Br J Pharmacol,2000,130(3):505-512.
26
Zheng TB, Shi X, Gao NR, et al. Expression of NK-1R and NK-2R in colon during acute necrotic pancreatitis[J]. J Pract Med,2002,18(12):1272-1274.
27
Kagnoff MF. The intestinal epithelium is an integral component of a communications network[J]. J Clin Invest,2014,124(7):2841-2843.
28
Lutgendorff F, Nijmeijer RM, Sandström PA, et al. Probiotics prevent intestinal barrier dysfunction in acute pancreatitis in rats via induction of ileal mucosal glutathione biosynthesis[J]. PLoS One,2009,4(2):e4512.
29
Wang H, Zhang W, Zuo L, et al. Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation[J]. Lett Appl Microbiol,2014,58(4):384-392.
[1] 陆婷, 范晴敏, 王洁, 万晓静, 许春芳, 董凤林. 超声引导下经皮穿刺置管引流对重症急性胰腺炎的疗效及应用时机的选择[J/OL]. 中华医学超声杂志(电子版), 2024, 21(05): 511-516.
[2] 李博, 贾蓬勃, 李栋, 李小庆. ERCP与LCBDE治疗胆总管结石继发急性重症胆管炎的效果[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 60-63.
[3] 张洁, 罗小霞, 余鸿. 系统性免疫炎症指数对急性胰腺炎患者并发器官功能损伤的预测价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 68-71.
[4] 康婵娟, 张海涛, 翟静洁. 胰管支架置入术治疗急性胆源性胰腺炎的效果及对患者肝功能、炎症因子水平的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 667-670.
[5] 党军强, 杨雁灵, 汪庆强, 尚琳, 朱磊, 项红军. 主动经皮穿刺引流治疗重症急性胰腺炎并发急性坏死物积聚的疗效分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 671-674.
[6] 方开萱, 翟亚奇, 张贯军, 陈升鑫, 陈德鑫, 刘文静, 梁雅文, 李明阳. 内镜逆行胰胆管造影术治疗胰腺分裂症的安全性与远期疗效[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 284-289.
[7] 赵月, 田坤, 张宗明, 郭震天, 刘立民, 张翀, 刘卓. 降钙素原对老年急性重度胆囊炎发生的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 801-806.
[8] 史清泉, 苗彬, 王烁, 陶琳, 沈晨. miR-181a-5p 靶向ATG5 抑制雨蛙素诱导的大鼠胰腺腺泡细胞AR42J自噬的机制研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 524-530.
[9] 曾明芬, 王艳. 急性胰腺炎合并脂肪肝患者CT 与彩色多普勒超声诊断参数与其病情和预后的关联性研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 531-535.
[10] 沈炎, 张俊峰, 唐春芳. 预后营养指数结合血清降钙素原、胱抑素C及视黄醇结合蛋白对急性胰腺炎并发急性肾损伤的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 536-540.
[11] 杨爽, 余宏亮, 谢敏. CT 与超声检查对急性胰腺炎合并脂肪肝的诊断价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 541-544.
[12] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[13] 商倩, 罗静, 卓振山, 苗园园, 吴静, 廖振林. 通腑泻浊法联合生长抑素对内镜逆行胰胆管造影治疗的急性胆源性胰腺炎患者预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 437-441.
[14] 刘春峰, 徐朝晖, 施红伟, 陈瑢, 马腾飞, 李鹏飞, 袁蓉, 陈建荣, 徐爱明. 机械通气患者肌肉减少症的诊断及其对预后的影响[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 820-825.
[15] 张平骥, 徐钰, 李天水, 庞文翼, 符师宁, 张梦圆. 重症患者镇静治疗现状及期望的调查研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 562-567.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?